Skip to content

Telemedicine versus hospital-based care for viral suppression and retention in care among people living with HIV (TELECARE-HIV): a randomized, open-label, non-inferiority trial

Telemedicine versus hospital-based care for viral suppression and retention in care among people living with HIV (TELECARE-HIV): a randomized, open-label, non-inferiority trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260626004
Enrollment
1258
Registered
2026-06-26
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV patients with viral suppression as HIV RNA less than 50 copies/mL HIV, Telemedicine, Antiretroviral Therapy (ART), Viral Suppression, Randomized Controlled Trial

Interventions

Participants allocated to the telemedicine group will receive ART follow-up through a web-based or mobile platform designed for clinically stable people living with HIV. The service will include authe
Telemedicine-based ART delivery,Conventional-hospital based care

Sponsors

Maharat Nakhon Ratchasima Hospital Institutional Review Board
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older. 2. Confirmed HIV infection and receipt of the same ART regimen through the outpatient HIV clinic of Maharat Nakhon Ratchasima Hospital for at least 6 months. 3. Most recent HIV viral load within 3-6 months before enrollment showing HIV RNA < 50 copies/mL. 4. Clinically stable, without acute illness or a condition requiring routine in-person hospital-based physician assessment as judged by the treating physician. 5. Access to a smartphone or other device and internet connection sufficient for study system use. 6. Able to communicate in Thai and read/respond to messages or use the telemedicine/web-based system independently or with regular assistance from a home caregiver.

Exclusion criteria

Exclusion criteria: 1. Clinically unstable condition, including current opportunistic infection, ongoing assessment or treatment of a major comorbidity, or physician judgment that close in-person follow-up is required. 2. Required pre-visit laboratory results are unavailable according to protocol. 3. Unable to use the telemedicine system sufficiently in practice despite instruction. 4. Unable to provide informed consent personally. 5. Pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Viral suppression 12 months Proportion of randomised participants with HIV RNA less than 50 copies/mL

Secondary

MeasureTime frame
Retention in care 6 and 12 months Proportion of participants remaining in care and receiving ART ,Missed visits 12 months Number or rate of scheduled visits/protocol service,Participant satisfaction 6 and 12 months Likert-scale questionnaire,Health-care personnel satisfaction 6 and 12 months Likert-scale questionnaire

Countries

Thailand

Contacts

Public ContactRattagan Kajeekul

Maharat Nakhon Ratchasima Hospital

rattagan_k@yahoo.com0619451942

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026